Advertisement

Topics

Array BioPharma Submits NDAs For Binimetinib & Encorafenib In Advanced Melanoma

08:25 EDT 5 Jul 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Array BioPharma Inc. (ARRY), a biopharmaceutical company focused on targeted small molecule drugs to treat cancer patients, announced Wednesday the submission of two New Dru...

Original Article: Array BioPharma Submits NDAs For Binimetinib & Encorafenib In Advanced Melanoma

NEXT ARTICLE

More From BioPortfolio on "Array BioPharma Submits NDAs For Binimetinib & Encorafenib In Advanced Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...